Live Med
  • Live
  • On Demand
    • Congresses
    • Web Events
  • Public
  • Specialty
    • Child Psychiatry
    • Dermatology
    • Forensic Medicine
    • Gynecology
    • Haematology
    • Medical Oncology
    • Neurology
    • Ophthalmology
    • Paediatric
    • Pathology
    • Pulmonology
    • Radiation Oncology
    • Rheumatology
    • Surgery
    • Surgical Oncology
    • Urology
    • Angiosurgery
    • Radiology
    • Allergology
    • Anesthesiology
    • Gastroenterology
    • General Medicine
    • Endocrinology
    • Medical Work
    • Cardiology
    • Social Medicine
    • Cytology
    • Microbiology (Medical Biopathology)
    • Neurosurgery
    • Nephrology
    • Orthopedics
    • Pathology Anatomy
    • Plastic Surgery
    • Nuclear Medicine
    • Physical Medicine and Rehabilitation
    • Thoracic Surgery
    • Children Surgery
    • Psychiatry
    • Otorhinolaryngology
  • Studio
  • Contact Us
  • ABOUT US
  • Support Q&A

LOG IN
REGISTER
LOG INREGISTER

  • EN
  • EL
  • Home
  • Categories
  • 17-01-2020
Go Back
Go Back

17-01-2020

18 L. Kaklamanis - WHO lung cancer histological classification.

18 L. Kaklamanis - WHO lung cancer histological classificati...

19 I. Gkiozos - Update on TNM staging system.

19 I. Gkiozos - Update on TNM staging system.

20 K. Tavernaraki - Radiomics: images are more than pictures.

20 K. Tavernaraki - Radiomics: images are more than pictures...

21 Discussion

21 Discussion

22 I. Kotteas - Is there a role for I-O monotherapy in the 1st Line mNSCLC?

22 I. Kotteas - Is there a role for I-O monotherapy in the 1...

23 V. Ramfidis - Is there a role for immunotherapy in the 2nd line mNSCLC?

23 V. Ramfidis - Is there a role for immunotherapy in the 2n...

24 A. Charpidou - Integration of immunotherapy in localized NSCLC.

24 A. Charpidou - Integration of immunotherapy in localized...

25 F. Yumuk - Optimal systemic treatment of patients with CNS involvement.

25 F. Yumuk - Optimal systemic treatment of patients with CN...

26 Discussion

26 Discussion

27 S. Lampaki - Planning the therapeutic journey to maximize the treatment outcomes in EGFR (+) NSCLC patients.

27 S. Lampaki - Planning the therapeutic journey to maximize...

28A. Asimakopoulou - Endocrinologic toxicity of ICIs.

28A. Asimakopoulou - Endocrinologic toxicity of ICIs.

29 D. Vassos - Pulmonary toxicity of ICIs.

29 D. Vassos - Pulmonary toxicity of ICIs.

30 D. Mandellos - Neurologic toxicity of ICIs.

30 D. Mandellos - Neurologic toxicity of ICIs.

31 A. Papaspiliou - Cases of special interest.

31 A. Papaspiliou - Cases of special interest.

32 E. Gӧker  - Optimal 1st line treatment for mutation naive patients.

32 E. Gӧker - Optimal 1st line treatment for mutation naive...

  • Next

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016

livemed white

Λογότυπο Livemed


© 2026 Live Med | Web Design by Ruler Digital Agency & CnC Tech